Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00756509
Show Display Options
Download search resultsDownload the search results for:
NCT00756509 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Nilotinib

Indicates status has not been verified in more than two years